Cargando…
Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462426/ https://www.ncbi.nlm.nih.gov/pubmed/37645671 http://dx.doi.org/10.1055/a-2122-7887 |
| _version_ | 1785098028718227456 |
|---|---|
| author | Matsumoto, Naoki Abe, Hiroto Kawasaki, Ryohei Tashiro, Yoshihito Noguchi-Sasaki, Mariko Harada, Suguru Yoneyama, Koichiro Niino, Tomomi Soeda, Tetsuhiro Yoshimura, Yasushi |
| author_facet | Matsumoto, Naoki Abe, Hiroto Kawasaki, Ryohei Tashiro, Yoshihito Noguchi-Sasaki, Mariko Harada, Suguru Yoneyama, Koichiro Niino, Tomomi Soeda, Tetsuhiro Yoshimura, Yasushi |
| author_sort | Matsumoto, Naoki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10462426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104624262023-08-29 Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan Matsumoto, Naoki Abe, Hiroto Kawasaki, Ryohei Tashiro, Yoshihito Noguchi-Sasaki, Mariko Harada, Suguru Yoneyama, Koichiro Niino, Tomomi Soeda, Tetsuhiro Yoshimura, Yasushi TH Open Georg Thieme Verlag KG 2023-08-28 /pmc/articles/PMC10462426/ /pubmed/37645671 http://dx.doi.org/10.1055/a-2122-7887 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
| spellingShingle | Matsumoto, Naoki Abe, Hiroto Kawasaki, Ryohei Tashiro, Yoshihito Noguchi-Sasaki, Mariko Harada, Suguru Yoneyama, Koichiro Niino, Tomomi Soeda, Tetsuhiro Yoshimura, Yasushi Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_full | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_fullStr | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_full_unstemmed | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_short | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_sort | characterization of anti-emicizumab antibodies using repository samples obtained in clinical studies of emicizumab conducted in japan |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462426/ https://www.ncbi.nlm.nih.gov/pubmed/37645671 http://dx.doi.org/10.1055/a-2122-7887 |
| work_keys_str_mv | AT matsumotonaoki characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT abehiroto characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT kawasakiryohei characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT tashiroyoshihito characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT noguchisasakimariko characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT haradasuguru characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT yoneyamakoichiro characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT niinotomomi characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT soedatetsuhiro characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT yoshimurayasushi characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan |